Covance
M&A activity drives record year for pharma outsourcing deals
December 11, 2015Sales and Marketing Covance, M&A, MA, labcorp, outsourcing
A drastic increase pharma industry in M&A activity has propelled the value of pharmaceutical outsourcing deals from $9.9 billion in …
LabCorp buys Covance for $6.1 billion
November 5, 2014Research and Development, Sales and Marketing CRO, Covance, king, labcorp, medical
US medical diagnostics firm LabCorp has entered the drug development business via a $6.1 billion deal to buy contract research …
Covance opens expanded Singapore lab
April 18, 2013Research and Development Covance
Covance has expanded its central laboratory facility in Singapore to meet growing demand for drug development services in the Asia-Pacific …
Contract research news in brief
December 12, 2012Research and Development AMRI, Covance, Dimensione Ricerca, INC Research, Perceptive Informatics, TFS
TFS buys Italian CRO Dimensione Ricerca, AMRI closes a US facility plus business development updates from Covance, Perceptive Informatics and …
Contract research news in brief
September 24, 2012Research and Development AMRI, Celerion, Covance, GNS Healthcare, INC Research, Knopp Biosciences, PPD, Vitalea Bioscience
A round-up of recent developments in the contract research sector, including updates from Covance/GNS, AMRI, Celerion, PPD, INC Research and …
Contract research news in brief
May 1, 2012Research and Development BML, Cetero Labs, Covance, Harlan and Chiltern, PRA
A round-up of recent developments in the contract research sector, featuring updates from PRA, Cetero Labs, Covance/BML, Harlan Labs CRS …
Contract research news in brief
January 17, 2012Manufacturing and Production, Research and Development AAIPharma and General Dynamics, Charles River Labs, Covance, ICON, ShangPharma
A round-up of developments in the contract research sector, including updates on Charles River Labs, ShangPharma, Icon, Covance, AAIPharma and …
Contract research news in brief
October 15, 2010Research and Development Clinipace, Covance, PPD, Quintiles, Synexus, cellectis
Our latest crop of contract research news includes updates from Clinipace, PPD, Cellectis bioresearch, Covance, Quintiles and Synexus. US contract …
Sanofi signs $2.2bn CRO deal
October 1, 2010Research and Development CRO, Covance, Sanofi-Aventis
Sanofi-Aventis has signed a major deal to contract out a wide range of drug development and laboratory services as part …
Contract research news in brief
September 20, 2010Research and Development Covance, Galapagos, MediData Solutions, MediSync BioServices, PPD, Quotient Bioresearch, i3
A round-up of recent news from the CRO sector, featuring updates from Covance, Quotient Bioresearch, PPD, i3, Galapagos, MediSync BioServices …
Contract research news in brief
June 18, 2010Research and Development CRO, ClinStar, Covance, ICON, Parexel, Phlexglobal, Quintiles, chiltern, contract research
Good news abounds in the CRO sector at the moment, with a raft of business expansions, investments, and new contracts …
Contract research news in brief
May 14, 2010Research and Development CRO, Clinipace, Covance, Encorium, IR Pharma, Imperial College, PPD, Parexel
Developments in the contract research sector this week include the opening of new offices for Parexel and PPD, the spin-out …
Mixed fortunes for major CROs in Q1
May 7, 2010Research and Development CRO, Covance, ICON, PPD, Parexel, contact research, contract research, contract research organisation
Leading contract research organisations (CROs) reported a mixed bag of financial results for the first three months of 2010, although …
Oracle buys eClinical specialist Phase Forward for $685m
April 20, 2010Research and Development Covance, Oracle, Phase Forward
Business software giant Oracle has taken a leap forward in the healthcare arena with a $685 million cash offer to …
Contract research news in brief
December 22, 2009Research and Development AAIPharma, Benten BioServices, CRO, Covance, ICON, PharmaVigilant, Phase Forward, SynRG
Our round-up of developments in the contract research sector includes updates from ICON, SynRG, AAIPharma, Covance, Benten BioServices, Phase Forward …
